Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-09-17FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Ziprasidone hydrochloride submitted by Apotex Corp., for an already approved generic product. Th…
-
FDA approval · 2025-09-16FDA Approved: SUBVENITE — Original Application (OWP Pharmaceuticals, Inc.)
The FDA approved SUBVENITE (lamotrigine) through an Original Application filed by OWP Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: The Police-Mental Health Linkage System [NA]
Completed clinical trial update on the Police-Mental Health Linkage System sponsored by Columbia University, studying severe mental disorder…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy [Phase 2, Phase 3]
A Phase 2/3 clinical trial at Michigan State University is evaluating low amplitude pulse seizure therapy versus standard ultra-brief right …
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: NeuroPsyBiT-BD Omics: Genomic & Epigenomic Biobank of Bipolar Disorder
This clinical trial is a genomic and epigenomic biobank study for Bipolar Disorder (NeuroPsyBiT-BD Omics) that is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-12FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA granted a supplemental approval for a generic quetiapine fumarate product from Hikma Pharmaceuticals USA Inc. (ANDA 090749). The approva…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Real-world Lithium Intake
This real-world study from the University of Aarhus is examining lithium intake in people with bipolar disorder and is currently recruiting …
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations [NA]
A Massachusetts General Hospital clinical trial is evaluating transcranial direct current stimulation (tDCS) to enhance executive function a…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Pain, Sleep Quality, Eating Habits and Physical Activity Level in Patients With Bipolar Disorder
Clinical trial update on an ongoing study evaluating pain, sleep quality, eating habits, and physical activity in people with Bipolar Disord…
-
FDA approval · 2025-09-04FDA Approved: PALIPERIDONE — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for paliperidone (generic paliperidone). The approval makes a generic ve…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
The UnMASCK study aims to unobtrusively monitor affective symptoms and cognition using keyboard dynamics, and the trial is currently active …
-
FDA approval · 2025-09-03FDA Approved: ZIPRASIDONE MESYLATE — Original Application (STERISCIENCE SPECIALTIES PRIVATE LIMITED)
FDA approved an original application for ziprasidone mesylate from SterisScience Specialties Private Limited, enabling a generic version of …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
A clinical trial is evaluating artificial intelligence models to detect Autism Spectrum Disorder, Major Depressive Disorder and other mental…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Digital Phenotypes for Predicting Depression
Clinical trial update describing a study that uses digital phenotypes to predict depression, sponsored by Korea University Anam Hospital. Th…
-
FDA approval · 2025-09-02FDA Approved: RISPERIDONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic risperidone through an Original Application for use in established indications.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: OLFACTION AND BIPOLAR DISODER [NA]
A completed clinical trial update from INSERM examining olfactory function in individuals with bipolar disorder.
-
FDA approval · 2025-09-02FDA Approved: RISPERIDONE — Original Application (Amneal Pharmaceuticals LLC)
FDA approval of a generic risperidone original application by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Transcranial Photobiomodulation for Executive Function in Bipolar Disorder [Phase 2]
Phase 2 trial evaluating transcranial photobiomodulation to improve executive function in Bipolar Disorder has completed. Results were poste…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Physical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia Patients
A completed clinical trial assessing physical fitness, physical activity level, depression, and quality of life in patients with bipolar dis…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: ERG Components in Schizophrenia and Bipolar Disorder Type I
DiaMentis' clinical trial researching ERG components in schizophrenia and Bipolar I disorder is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: EPI-MINN: Targeting Cognition and Motivation - National [NA]
An update on the EPI-MINN trial from the University of Minnesota evaluating cognition and motivation in several psychotic disorders; the stu…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression
This clinical trial update notes an ongoing study led by University of Texas Southwestern Medical Center investigating depression and treatm…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders [NA]
A terminated clinical trial sponsored by University Hospital, Strasbourg, studying time, self, and spontaneous mental activities in patients…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020) [Phase 1]
Phase 1 results from a Merck-sponsored study of MK-8189 in participants with Bipolar I Disorder have been completed and results posted on 20…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents [NA]
A clinical trial from Shanghai Mental Health Center is investigating prediction and intervention effects of rehabilitation status for severe…